Skip to main content
Clinical Trials/NCT01643395
NCT01643395
Completed
Phase 3

VertebrOpLasty Versus Conservative Treatment in Acute Non Osteoporotic Vertebral Fractures

University Hospital, Clermont-Ferrand1 site in 1 country99 target enrollmentSeptember 2010

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Vertebral Compression Fracture
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
99
Locations
1
Primary Endpoint
Disability scale
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this protocol is to prove the efficacy of vertebroplasty in patients suffering from acute non osteoporotic vertebral compression fracture.

Vertebroplasty consists in the injection of cement (PMMA) in the damaged vertebral body to prevent further collapse.

Our study will compare vertebroplasty versus conservative therapy (brace).

Detailed Description

The study is a prospective, randomized trial comparing conservative treatment (brace) and vertebroplasty in acute (less than 15 days after trauma) traumatic vertebral compression fracture (VCF) type A according Magerl classification

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
April 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 - 70 year old
  • volunteers
  • Vertebral compression fractures Magerl type A
  • Acute Trauma (less than 15 days)
  • Between T5 and L5
  • Patient able to undergo both vertebroplasty and conservative treatment
  • Consent form obtained

Exclusion Criteria

  • Neural arch fracture
  • C1 to T4 fracture
  • Neurologic symptoms caused by the fracture
  • Encephalic trauma with Glasgow Coma Scale less than 15
  • Ongoing cancer
  • Routine painkillers intake
  • Local or systemic infection
  • Coagulation's disorder
  • Pregnancy
  • Involvement in an another clinical trial

Outcomes

Primary Outcomes

Disability scale

Time Frame: at 1 month

Secondary Outcomes

  • Spine radiological measurements(at 1, 3 and 6 months)
  • Disability and qol(at 3 and 6 months)

Study Sites (1)

Loading locations...

Similar Trials